Last updated 14th December 2021
We commit to ensuring the quality, safety and reliable supply of our products. If the supply of our medicines or vaccines is disrupted in Australia we will publish details here.
At this unprecedented time, we are actively managing our global supply chains to minimise potential disruption, and we are monitoring the situation closely. We will put the needs of patients first at all times.
At present, with the exception of specific supply disruptions as outlined below, we have adequate stock in place in Australia.
Priorix Tetra (measles, mumps, rubella, and varicella)
We are currently experiencing an extended supply shortage of Priorix Tetra vaccine, (measles, mumps, rubella, and varicella) vaccine, live, attenuated), and are currently diverting all of our private market supplies to government programs. We expect this shortage to continue into 2022, with a supply outage for private and government markets from the beginning of February 2022 through to mid-July 2022. An alternative vaccine remains available in the private and public markets, and therefore, we do not anticipate significant impacts for patients. For further questions, please contact your healthcare provider.
Stevia-A Cream 0.025% and 0.05% Strength
GSK is experiencing a supply outage of Stevia-A cream (tretinoin) from 15 December 2021 to 8 February 2022 for the 0.025% strength and from 14 December 2021 to 17 February 2022 for the 0.05% strength. We are currently working on ways to expedite shipments to Australia. For further questions, please contact your healthcare provider.
GSK will be experiencing a shortage of Varilrix (live varicella vaccine) in the private market from mid-November 2021 until mid-January 2022. We are currently working on ways to expedite shipments to Australia, and in the meantime, we understand that an alternate varicella vaccine remains available in the private market. We do not anticipate significant impacts for patients. For further questions, please contact your healthcare provider.
Please visit the TGA website for ongoing updates to supply.
For more information on GSK's medicines or vaccines, please contact GSK medical information on 1800 033 109.